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1. Introduction 
Glioblastoma multiforme (GBM) is the most common form of malignant brain cancer and 
persist as serious clinical and scientific problems. The current standard of therapy for GBM 
patients, include surgery, radiotherapy and chemotherapy with temozolomide, produces a 
median survival of only 14.6 months (Stupp et al., 2005). Now, new intervention is 
increasingly being tested, particularly with inhibitors of neo-angiogenesis and growth factor 
receptors, and high throughout profiling studies are leading to the discovery of novel 
genetic alterations and signaling pathways. The Cancer Genome Atlas Network recently 
catalogs recurrent genomic abnormalities in GBM, and proposes a molecular classification of 
GBM into Proneural, Neural, Classical, and Mesenchymal subtypes and integrates 
multidimensional genomic data to establish patterns of somatic mutations and DNA copy 
number (Verhaak et al., 2010). In recent years, microRNAs (miRNAs), small noncoding RNA 
molecules, have been identified in the progression of various human cancers and used to a 
notable molecular label to cancers. In glioma, miR-21, miR-221, miR-222, miR-181a and miR-
125b have been proven to play critical roles in gliomagenesis and proposed as novel targets 
for antiglioma therapies (Shi et al., 2008; Shi et al., 2010; Zhang et al., 2009b; Zhang et al., 
2010c; Zhou et al., 2010a; Zhou et al., 2010b). Thus, molecular regulation of glioma is 
comprehensive and still unclear and under further investigation. 
Biomedical literature is growing at a double-exponential pace, with approximately 20 
million publications in MEDLINE. Up to now, there have been more than 50 thousand of 
glioma-related publications in MEDLINE (Pubmed with: glioma). Thus, a massive wealth of 
information is embedded in the literature and waiting to be discovered and extracted. 
Literature mining is a promising strategy to utilize this untapped information for 
knowledge discovery and has been applied successfully to various biological problems 
including the discovery and characterization of molecular interactions (protein-protein, 
gene-protein, gene-drug, protein sorting and molecular binding) (Friedman et al., 2001; 
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Rindflesch et al., 2000; Sekimizu et al., 1998). As no searchable records are available to 
efficiently retrieve information relevant to molecular network in glioma, we extracted 
glioma-related genes and miRNAs by data mining Pubmed abstracts and established glioma 
associated network based on these genes and miRNAs to identify key signalings and 
miRNA regulatory module in glioma. 
2. Results 
2.1 Identification of glioma-related genes and miRNAs 
For glioma we queried Pubmed with: glioma[title] AND ("1980/01/01"[PDAT] : 
"2010/04/01"[PDAT]). It led to the identification a total of 670 genes and 14 miRNAs that 
interacted with glioma. The top 10 glioma-related genes were listed in Table 1. These 14 
glioma-related miRNAs were miR-21, miR-34a, miR-221, miR-222, miR-10b, miR-125b, miR-
128, miR-146b, miR-15b, miR-181a, miR-196a, miR-26a, miR-451 and miR-9. Additionally, 
we score the journals describing these genes and miRNAs, and the top 10 journals were 
listed in Table 2. 
 
Gene PubMed Count 
EGFR 130 
VEGF 123 
GFAP 87 
TRAIL 71 
CD95 52 
JNK 52 
ERK 49 
IFN 48 
PTEN 47 
NGF 47 
Table 1. The top 10 glioma-related genes. 
 
Journal Count 
Cancer Res. 133 
J. Neurooncol. 103 
Oncogene 53 
J. Neurochem. 46 
J. Neurosurg. 38 
Int. J. Cancer 37 
J. Biol. Chem. 36 
Biochem. Biophys. Res. Commun. 33 
Clin. Cancer Res. 33 
Table 2. The top 10 journals describing glioma-related genes and miRNAs. 
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2.2 Biological function of glioma-related genes 
To better understand the biological role of glioma-related genes, the catalogued genes were 
visualized using Gene Ontology (GO) terms and pathway analysis. The Gene Ontology 
(GO) provides a structured and controlled ontology for describing gene products in terms of 
their associated molecular function, biological process, or cellular component in a species-
independent manner. The molecular function enrichment revealed that 22 GO terms 
appeared to be significantly enriched and most glioma-associated genes encode for protein 
binding. In the biological process category，the genes mainly participated in signaling 
transduction, response stress, cell differentiation and regulation of cell proliferation. Finally, 
the cellular component category found that products of these genes were active mainly in 
cytoplasm membrane (Table 3). 
 
Category GO term 
molecular 
function 
protein binding, protein dimerization activity, signal transducer 
activity, cytokine activity, enzyme binding, growth factor activity, 
growth factor binding, receptor activity, protein kinase activity, 
glycosaminoglycan binding, kinase binding, enzyme regulator activity, 
G-protein-coupled receptor binding, carbohydrate binding, peptide 
receptor activity, collagen binding, polysaccharide binding, kinase 
activity, ATP binding, enzyme inhibitor activity, transmembrane 
receptor protein tyrosine kinase activity, adenyl nucleotide binding 
biological 
process 
response to stress, regulation of cell proliferation, cell differentiation, 
regulation of phosphorylation, regulation of immune system process, 
negative regulation of cell proliferation, cell proliferation, anti-
apoptosis, apoptosis, neurogenesis, response to hormone stimulus, 
hemopoiesis, regulation of protein kinase activity, immune response, 
signal transduction, inflammatory response, cell migration, 
angiogenesis, cell communication, phosphorylation, gliogenesis, cell 
cycle process 
cellular 
component 
intrinsic to plasma membrane, integral to plasma membrane, plasma 
membrane, extracellular region, cell projection, vesicle, nucleoplasm, 
cytosol, cell soma, secretory granule, platelet alpha granule, 
transcription factor complex, apical plasma membrane 
Over-represented GO terms were identified after multiple testing adjustments (P-value<0.05). 
Table 3. Set of GO terms with highly enriched genes. 
To further explore the pathway involved in these genes, we searched KEGG database for 
their pathway information. 16 pathways whose P-value was less than 0.01 were kept (Table 
4). The most top enriched pathway is p53 signaling pathway, including 27 genes and Toll-
like receptor signaling pathway including 33 genes. 
2.3 Interaction network of glioma-related genes 
To uncover the potential interaction networks or synergistic effects of these glioma-related 
genes, we employed each gene set as queries and searched for their interaction partners by 
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accessing the database STRING. STRING integrates different public databases containing 
information on direct and indirect functional protein–protein associations by benchmarking 
them against the common reference set, KEGG pathway database. 204 genes had 
interactions in the database STRING. We next tried to connect these genes into a network to 
identify biologically informative linker genes which were statistically enriched for 
connections to member of glioma-related gene list. Figure 1A summarized PIK3CA, PIK3CB 
and JAK2 three queries served as "hubs" (label with red circle), which has high connection 
and was an indicator for essentialness in a network. Surprisingly, further analysis found that 
PIK3CA, PIK3CB and JAK2 were associated with signaling transduction, MAPK pathway, 
growth factor, cell apoptosis, cell proliferation, cell adhesion and cell migration (Figure 1B). 
Given that PIK3CA and PIK3CB encode the protein PI3K subunit p110ǂ and p110ǃ, 
respectively, these data suggested that PI3K and JAK2 signalings provided excellent 
biomarkers for glioma aggressiveness. 
 
Pathway Count Enrichment P-value 
p53 signaling pathway 27 0 
Toll-like receptor signaling pathway 33 0 
Apoptosis 30 9.80E-10 
Cytokine-cytokine receptor interaction 65 2.48E-09 
Glioma 23 8.80E-08 
MAPK signaling pathway 51 1.24E-06 
ErbB signaling pathway 24 1.02E-05 
Focal adhesion 40 1.12E-05 
Cell cycle 28 1.28E-05 
T cell receptor signaling pathway 27 1.47E-05 
Adipocytokine signaling pathway 20 3.11E-05 
Chemokine signaling pathway 38 3.22E-05 
Neurotrophin signaling pathway 29 4.10E-05 
VEGF signaling pathway 18 0.003731 
Adherens junction 18 0.003731 
Over-represented KEGG pathways were identified after multiple testing adjustments (P-value<0.05). 
Table 4. Set of signaling pathways with highly enriched genes. 
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Fig. 1. Visualization of glioma-related gene interaction network. 
(A) Connectivity analysis was performed using the Search Tool for the Retrieval of 
Interacting Genes/Proteins (STRING) to generate glioma-related gene knowledge-driven 
network, as described in Methods. Analysis revealed PI3KCA, PI3KCB and JAK2 are hub 
genes with P-value<0.001, which had an influential role in network stability. 
(B) PI3K and JAK2 hub signalings located at the key status of glioma-related gene 
knowledge-driven network, and exerted a wide effect on kinds of biological functions and 
pathways, including signaling transduction, MAPK pathway, growth factor, cell apoptosis, 
cell proliferation, cell adhesion and cell migration. Purple lines correspond to activation, 
blue lines to inhibition, and yellow lines to association. Red circles (PI3KCA, PI3KCB and 
JAK2) are indicated for hub genes. 
2.4 Glioma-related miRNA pathway 
Because each miRNA target prediction program uses a different computer-aided algorithm 
for prediction, encompassing all these methods will probably produce a more reliable model 
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of target prediction. Thus, a union target gene list of 14 glioma-related miRNAs was 
generated from 3 target prediction programs (PicTar, TargetScan and miRanda). To further 
explore the signaling pathway in these target genes, pathway analysis was performed. Table 
5 showed that p53 signaling pathway, Apoptosis, Focal adhesion, MAPK signaling pathway, 
Toll-like receptor signaling pathway and Cell cycle pathways were significantly over-
represented. Actually, these 6 pathways were included in the pathways of glioma-related 
genes. These findings imply that glioma-related genes and miRNAs prefer a common set of 
signaling pathways.  
 
Pathway Count Enrichment P-value 
p53 signaling pathway 19 8.67E-09 
Apoptosis 21 2.4E-08 
Focal adhesion 26 0.000123 
MAPK signaling pathway 30 0.000499 
Toll-like receptor signaling pathway 15 0.005773 
Cell cycle 16 0.006547 
Over-represented KEGG pathways were identified after multiple testing adjustments (P-value<0.05). 
Table 5. Set of signaling pathways with highly enriched microRNA targets. 
In order to construct the network between glioma-related miRNAs and the signaling 
pathway, integrated analysis of the targets of glioma-related miRNAs was performed. This 
procedure obtained 6 miRNA-pathway networks. For instance, p53 signaling pathway 
network contained 12 miRNAs (miR-21, miR-34a, miR-221, miR-222, et al) and 19 genes 
(PTEN, CDK6, BBC3, et al) (Fig.2). 
 
 
Fig. 2. Visualization of miRNA-p53 pathway network in glioma. 
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The network was visualized with Medusa software. Blue quadrangles represent glioma-
related miRNAs. Red circles represent miRNA targets that were overlapped by glioma-
related geges. 
3. Discussion 
The overall utility of our data mining approach, including the strategy for constructing 
interaction networks, is to explore biological mechanisms involved in glioma progression. In 
this study, we obtained 670 genes and 14 miRNAs that interacted with glioma and 
generated interaction networks from abstract-based text mining. Importantly, our analysis 
identified PI3K and JAK2 hub signalings and miRNA regulatory module in glioma. 
3.1 Core signalings in glioma 
By integration of PubMed text mining, homology prediction, gene neighbor, protein-protein 
interaction, gene fusion and other data sources, we constructed glioma-related genes 
knowledge-driven network. Further analysis revealed that PI3K and JAK2 hub signalings 
that had an influential role in network stability, located at the key status of glioma-related 
genes knowledge-driven network. These signaling exerted a wide effect on kinds of 
biological functions and pathways, including signaling transduction, MAPK pathway, 
growth factor, cell apoptosis, cell proliferation, cell adhesion and cell migration. Further, 
integrating GO and pathway analysis, data revealed that proliferation without control and 
invasive growth were the essential characteristic of glioma. 
PI3Ks are heterodimers comprised of a regulatory subunit (p85) and a catalytic subunit 
(p110). Activated receptor tyrosine kinases recruit the PI3 kinase complex to the membrane 
via the p85 regulatory subunit, thereby activating the catalytic subunit p110, which then 
phosphorylates phosphatidylinositol-4,5-bisphosphate (PIP2) to phosphatidylinositol-3,4,5-
trisphosphate (PIP3). PIP3 recruits protein AKT to the plasma membrane where AKT is 
phosphorylated at Thr308 and Ser473 (Cheng et al., 2009). A high frequency of mutations in 
PIK3CA, the gene encoding the p110alpha subunit of PI3K, was found in glioblastoma 
(Gallia et al., 2006; Kita et al., 2007). Our recent data showed that PI3K activity were greatly 
increased with the ascending of tumor grade and correlated positively with AKT2 
expression (Wang et al., 2010). Activation of PI3K/Akt signaling cascade results in cell 
survival and proliferation as well as inhibition of cell apoptosis through regulating 
downstream targets. AKT contributes to glioma cell migration and invasion by regulating 
the formation of cytoskeleton, influencing adhesion and MMP2/9 expression (Pu et al., 2004; 
Zhang et al., 2009a; Zhang et al., 2010d). AKT promotes the cell cycle progression by 
suppression of cyclin-dependent kinase inhibitors p21 and p27 and increase of Cyclin D1 
(Guillard et al., 2009; Koul et al., 2010; Pu et al., 2006). AKT inhibits cell apoptosis by 
inactivation of caspase pathway, and activation of BCL2, NFκB and mTOR signaling cascade 
(Jiang et al., 2009; Ruano et al., 2008; Zhang et al., 2010d). Further, prosurvival signaling by 
PI3K contributes to therapeutic resistance in the setting of established antiglioma therapies. 
Several studies have shown that PI3K inhibition sensitizes glioma cells to radiation and 
chemical therapy (Opel et al., 2008; Prevo et al., 2008). Additionally, our study recently has 
showed that co-suppression of PI3K and AKT exerts significant proliferation and invasion 
inhibition effects on glioma cells (Fu et al., 2009). In the current study, we found that is PI3K 
is a molecular hub in glioma-related genes knowledge-driven network, and associated with 
a wide variety of cell biological functions and signaling pathways. Therefore, it is urgent to 
develop novel therapies for targeting PI3K/AKT signaling in glioma treatment. 
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In our case, network analysis also identifies a new candidate hub gene JAK2 in 
glioblastoma. JAKs, which have four members, JAK1, JAK2, JAK3 and Tyrosine kinase 2 
(Tyk2) in mammals, are non-receptor tyrosine kinases involved in upstream intracellular 
signaling pathways that become activated after extracellular ligand binding to a variety of 
cytokine and growth-factor receptors (Pesu et al., 2008). JAK2 is known to be able to 
phosphorylate members of the signal transducers and activators of the transcription (STAT) 
protein family, subsequently leading them to translocate to the nucleus and bind to specific 
DNA sequences in the promoters of multiple responsive genes (Ghoreschi et al., 2009; Rane 
and Reddy, 2000). STAT family has been reported to be involved in the development of 
glioma. Of note, STAT3, is aberrantly activated in human glioblastoma tissues, and this 
activation is implicated in controlling critical cellular events thought to be involved in 
gliomagenesis, such as cell cycle progression, apoptosis and angiogenesis (Brantley and 
Benveniste, 2008). Recently, a glioma-specific regulatory network has revealed the 
transcriptional module that activates expression of mesenchymal genes in malignant glioma 
and STAT3 is one of key transcription factors necessary in human glioma cells for 
mesenchymal transformation (Carro et al., 2010). Additionally, nuclear staining of phospho-
STAT5 is overexpressed in glioma tissues, and cytoplasm staining of STAT5b is markedly 
increased in glioblastoma multiforme compared with that in normal brain (Kondyli et al., 
2010; Liang et al., 2009). Reduction of STAT5b inhibits glioma cell growth, cell cycle 
progression, invasion and migration through regulation of gene expression, such as Bcl-2, 
p21, p27 and VEGF (Liang et al., 2009). As another member of STAT family, STAT1 is up-
regulated in the majority of glioblastomas (Haybaeck et al., 2007). Little evidence exists to 
show the mechanism of JAK2 (upstream regulator of STAT family) involved in 
glomagenesis. However, data mining analysis displays that JAK2 occupies a core regulatory 
node of glioma-related genes knowledge-driven network. These data indicate that 
modulation of the mechanism responsible for JAK2 in glioma would help us to elucidate the 
development of glioma and inhibition of JAK2/STAT signaling could be used as a new 
therapeutic strategy to treatment glioma. The JAK/STAT pathway plays a central role in 
principal cell fate decisions, regulating the processes of innate immunity, adaptive 
immunity, cell proliferation, differentiation, and apoptosis. 
In addition, we found the gene CTNNB1 (encoding ǃ-catenin) at the lower right corner of 
Fig.1 would warrant further investigation. ǃ-catenin and Tcf-4 are the core components of 
the canonical Wnt/ǃ-catenin/Tcf pathway, which is a crucial factor in the development of 
many cancers (MacDonald et al., 2009; Ying and Tao, 2009). ǃ-catenin accumulates in the 
nucleus, where it interacts with coregulators of transcription including Tcf-4 and Lef-1 to 
form a ǃ-catenin/Tcf/Lef complex. This complex regulates transcription of multiple genes 
involved in cellular proliferation, differentiation, survival and apoptosis, including Fra-1, c-
myc and Cyclin D (Wang et al., 2002; Yochum et al., 2008). Recently several reports have 
showed that aberrant activation of Wnt/ǃ-catenin/Tcf signaling pathway is an important 
contributing factor in gliomas (Liu et al., 2010; Pu et al., 2009; Sareddy et al., 2009). ǃ-catenin 
and Tcf-4 were up-regulated in glioma tissues in comparison to normal brain tissues. 
Knockdown of ǃ-catenin by siRNA in human glioma cells inhibited cell proliferation and 
invasive ability, induced apoptotic cell death and delayed the tumor growth (Pu et al., 2009). 
However, up to now, little direct evidence exists to show the mechanism of ǃ-catenin and 
Tcf-4 involved in gliomagenesis.  
Actually, our data doses not well confirm the update results of The Cancer Genome Atlas 
Network (TCGA) (Verhaak et al., 2010). TCGA catalogs recurrent genomic abnormalities in 
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GBM, and describes a gene expression-based molecular classification of GBM into 
Proneural, Neural, Classical, and Mesenchymal subtypes. Aberrations and gene expression 
of EGFR, NF1, and PDGFRA/IDH1 each define the Classical, Mesenchymal, and Proneural 
subtypes, respectively. Despite of the differences of two studies, our data showed another 
approach to explore the mechanism involved in glioma using existing data. 
3.2 MiRNA regulatory module in glioma 
miRNAs are a new class of small, non-coding RNAs located in noncoding regions or the 
introns of the genome, and regulate gene expression by binding to the 3’-untranslated 
region (3’-UTR) of specific mRNAs. Extensive studies have indicated that miRNAs could 
function as oncogenic miRNAs or tumor suppressor miRNAs, playing crucial roles in 
carcinogenesis. Expression profiling of glioma has unveiled miRNA signatures that not only 
distinguish glioma from normal tissues, but can also differentiate histotypes or molecular 
subtypes with altered genetic pathways (Ciafre et al., 2005; Lavon et al., 2010). Our data 
mining analysis showed that 6 pathways involved in 14 glioma-related miRNAs, in line 
with the pathway analysis of glioma-related genes, indicating that glioma-related genes and 
miRNAs exert an effect on a common set of signaling pathways. Moreover, we found that 
the pathway regulatory control mediated by miRNAs differs from pathway to pathway and 
the targets of a specific miRNA are significantly enriched in multiple pathways. In p53 
signaling pathway network, 12 miRNAs and 19 genes are involved. Among these miRNA 
and target gene relationships, MDM2, CDK6, CDKN2A and CCNE1 are successfully 
identified as direct targets of miR-221, miR-34a, miR-125b and miR-15b, respectively (Kim et 
al., 2010; Pogue et al., 2010; Sun et al., 2008; Xia et al., 2009). Our data recently showed that 
miR-221 and miR-222 directly modulate PTEN expression via targeting PTEN 3’-UTR 
(Zhang et al., 2010a). In addition, we have also evidenced that BBC3, also named p53 up-
regulated modulator of apoptosis (PUMA), is a new target of miR-221, consistent with 
bioinformatics analysis (Zhang et al., 2010b). Further, a recent publication revealed that 
miR-21 can impair p53-mediated apoptosis in response to chemotherapeutic (doxorubicin)-
induced DNA damage, therefore contributing to drug resistance in glioblastoma cells 
(Papagiannakopoulos et al., 2008). Thus, modulation of these p53-related targets by miR-21 
may potentially explain previous observation that p53 signaling pathway were up-regulated 
in response to miR-21 knockdown (Frankel et al., 2008). These exciting results prompt us to 
further elucidate the intricacy of the interaction between miRNAs and the signaling 
pathway. 
In conclusion, using data mining analysis, we construct glioma-related genes knowledge-
driven network and show that PI3K and JAK2 hub signalings are key steps leading to 
oncogenesis in glioma, and further propose miRNA regulatory module in glioma. These 
data demonstrate the power of data mining strategies as tools for biological discovery and 
identify core signalings and miRNA regulatory module in glioma, suggesting that the 
application of this strategy to consolidate all existing data for other diseases may yield 
important discoveries in disease pathogenesis. 
4. Experimental procedures 
4.1 Natural language processing (NLP) system 
Medline/PubMed is used as information source for bioinformatics text mining. Medline 
abstracts were retrieved using National Center for Biotechnology Information (NCBI) 
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PubMed portal. We queried Pubmed with: glioma[title] AND ("1980/01/01"[PDAT] : 
"2010/04/01"[PDAT]). All abstracts were downloaded as HTML text without images and 
then converted into XML documents. Sentence tokenization was performed with Lingpipe 
tools. Subsequent analysis is based on the sentence as the basic units. Gene mentions were 
tagged using ABNER (Settles, 2005). To solve the matter of plethora of gene aliases, all gene 
mentions were normalized to Entrez gene (http://www.ncbi.nlm.nih.gov/Entrez/) official 
gene symbols. Only sentences with glioma, the genes were selected. 
In order to test the null hypothesis 'the relationship between glioma and the gene is 
random', hypergeometric distribution test was employed. Let N be the total number of 
PubMed abstracts and m, n be the number mentions in PubMed for glioma and a related 
gene, respectively. 
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The "glioma-gene" relations with P-value<0.05 were then summarized and subjected to a 
relational database for further analysis. 
4.2 Gene ontology analysis 
Gene ontology analysis was performed by GSEA Base package of BioConductor 
(http://www.bioconductor.org/). The glioma-related genes were performed a gene set 
enrichment analysis based on the gene ontology (GO) categories. 
4.3 Pathway analysis 
Expression Analysis Systematic Explorer (EASE) (Hosack et al., 2003) was used to analyze 
KEGG pathways. Over representation of genes in a KEGG pathway is present if a larger 
fraction of genes within that pathway is differentially expressed compared with all genes in 
the genome. The "glioma-gene" relationships retrieved by our NLP system were filtered by 
pathway enrichment analysis. The links between glioma and related genes were then 
visualized in Cytoscape software (Cline et al., 2007) (http://www.cytoscape.org/). Genes 
were grouped according to pathways. Genes that involves in multiple pathways are 
assigned to a single pathway with the smallest enrichment P-value. 
4.4 Gene network analysis 
Integrating PubMed text mining, homology prediction, gene neighbor, protein-protein 
interaction, gene fusion and other data sources through the Search Tool for the Retrieval of 
Interacting Genes/Proteins (STRING), we created glioma-related genes knowledge-driven 
network (von Mering et al., 2005). Linker genes below a P-value threshold of 0.01 were 
identified as "hubs". The results from the search are saved in data files describing links 
between two genes and then handled in Medusa software. 
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4.5 Target gene prediction and pathway analysis of miRNAs 
Three computational tools: TargetScan v5.1 (http://www.targetscan.org/), miRanda v5 
(http://microrna.sanger.ac.uk/), PicTar ver. March 26, 2007 (http://pictar.mdc- berlin.de/) 
were utilized to identify miRNA targets in 3'-UTR of genes. The union of these results was 
listed for further analysis. These targets were used to analyze KEGG pathways.  
4.6 MiRNA-target network analysis 
The overlap of target genes of glioma-related miRNAs predicted by computational tools and 
glioma related genes derived from NLP analysis was calculated. A bipartite network of 
microRNAs and corresponding target genes was constructed. The network was displayed in 
separated pathways. 
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